Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Infection, inflammation, height, and longevity
2005 Standout
Complement Factor H Polymorphism and Age-Related Macular Degeneration
2005 StandoutScience
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Infective Endocarditis
2005 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Universal Definition of Myocardial Infarction
2007 Standout
Use of the Automatic External Defibrillator in the Management of Out-of-Hospital Cardiac Arrest
1988
C-reactive protein elevation and early outcome in patients with unstable angina pectoris
1997
Low status control, high effort at work and ischemic heart disease: Prospective evidence from blue-collar men
1990
Antibiotic Treatment ofChlamydia pneumoniaeafter Acute Coronary Syndrome
2005 Standout
C-Reactive Protein Levels and Outcomes after Statin Therapy
2005 Standout
C-reactive protein: a critical update
2003 Standout
Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention
2002 Standout
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
1995 Standout
Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC)
2008
C-reactive protein as a marker for acute coronary syndromes
1997
Coordinated Transcription of Key Pathways in the Mouse by the Circadian Clock
2002 Standout
High Sensitivity C-reactive Protein: An Emerging Role in Cardiovascular Risk Assessment
2002
A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease
1999 Standout
Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease
1998 Standout
Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation
2001
Increased telomerase activity and comprehensive lifestyle changes: a pilot study
2008 StandoutNobel
Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial
2001
Prosthetic Valve Endocarditis in the ICU
1995
From concept to standard-of-care? Review of the clinical experience with automated external defibrillators
1989
Elevated C-Reactive Protein Levels in Overweight and Obese Adults
1999 Standout
Impact of Obstructive Sleep Apnea on Clinical and Angiographic Outcomes Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome
2006
Aortic root replacement with cryopreserved allograft for prosthetic valve endocarditis
2002
Circadian Variation of Fibrinolytic Activity in Blood
1991
Peri-procedural myocardial injury: 2005 update
2005
C-Reactive Protein and secondary prevention of coronary events
2001
Inflammatory markers and coronary heart disease
2002
Third Universal Definition of Myocardial Infarction
2012 Standout
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
1997 Standout
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
The TNF and TNF Receptor Superfamilies
2001 Standout
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
2000 Standout
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
1994 Standout
Effect of Clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein
2001
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
Endothelial modulation of coronary tone
1988
Human viral cardiomyopathy
2003
Inflammatory pathways in atherosclerosis and acute coronary syndromes
2001
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Markers of Inflammation and Cardiovascular Disease
2003 Standout
Inflammation as a Risk Factor for Atrial Fibrillation
2003 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Role of circulatory congestion in the cardiorespiratory failure of obesity
1976
Air Pollution and Cardiovascular Disease
2004 Standout
Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention
2003 Standout
Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein Style. A statement for health professionals from a task force of the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, and the Australian Resuscitation Council.
1991 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Diaphragmatic energy expenditure in chronic respiratory failure
1977 Standout
Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable Angina
1999
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy
1999 Standout
Inflammation and Atherosclerosis
2002 Standout
Electrochemiluminescence (ECL)
2004 Standout
Gene-Targeted Mice Lacking the Trex1 (DNase III) 3′→5′ DNA Exonuclease Develop Inflammatory Myocarditis
2004 StandoutNobel
Rosuvastatin in the Primary Prevention of Cardiovascular Disease Among Patients With Low Levels of Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein
2003
Risk of Myocardial Infarction and Angina in Patients With Severe Peripheral Vascular Disease
2002
Novel Clinical Markers of Vascular Wall Inflammation
2001
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells
2000 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
“Variant” angina: One aspect of a continuous spectrum of vasospastic myocardial ischemia
1978
Endothelium‐derived nitric oxide: actions and properties
1989 StandoutNobel
Coronary Plaque Disruption
1995 Standout
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
Role of C-Reactive Protein in Cardiovascular Disease
2003
Need to Test the Arterial Inflammation Hypothesis
2002
Abciximab Suppresses the Rise in Levels of Circulating Inflammatory Markers After Percutaneous Coronary Revascularization
2001
Air Pollution and ST-Segment Depression in Elderly Subjects
2005
New insights into the cellular mechanisms of vasospas
1985
Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary Arteries
1986 Standout
C-reactive protein: a critical update
2003 Standout
Incremental Prognostic Value of Elevated Baseline C-Reactive Protein Among Established Markers of Risk in Percutaneous Coronary Intervention
2001
INTENSIVE LIFESTYLE CHANGES MAY AFFECT THE PROGRESSION OF PROSTATE CANCER
2005
C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men
1999 Standout
Endothelial Function and Dysfunction
2007 Standout
Works of A. Maseri being referenced
The risk and cost-effective individual patient management: The challenge of a new generation of clinical trials
1997
Aspirin, but not heparin, suppresses the transient increase in thromboxane biosynthesis associated with cardiac catheterization or coronary angioplasty
1993
Localized left ventricular aneurysms with normal global function caused by myocarditis
1992
Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty
1999
Usefulness of a third holter lead for detection of myocardial ischemia
1994
Inflammation and Acute Coronary Syndromes
2000
Risk stratification of patients undergoing peripheral vascular revascularization by combined resting and dipyridamole echocardiography
1998
Correction of recirculation in regional blood flow studies by residue detection.
1974
Safety and effectiveness of a portable external automatic defibrillator‐pacemaker
1983
[Pathogenetic mechanisms of angina pectoris].
1975
Pulmonary vascular distensibility and lung compliance as modified by dextran infusion and subsequent atropine injection in normal subjects.
1966
Predisposing Conditions for Acute Ischemic Syndromes
1989
Ergonovine-induced myocardial ischemia: no role for serotonergic receptors?
1984